Novonix Limited risk profile
75 Stretched several inputs deteriorating together
Measured 1 September 2026 from GC3's filed statements. Recomputed nightly.
75 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 83 | Acute | Stable | Drawdown from the 52-week high — 90.3% |
| Operating pressure | 58 | Elevated | Easing | Operating-margin drift — -75.8 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -1.43x |
| Leverage and coverage | 94 | Acute | Stable | Net debt to EBITDA |
| Competitive position | 70 | Stretched | Stable | Operating-margin gap against peers — -864.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.